Literature DB >> 11673485

Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity.

A A Bickerstaff1, J J Wang, R P Pelletier, C G Orosz.   

Abstract

It was shown >20 yr ago that mice will spontaneously accept renal allografts in the absence of immunosuppression, but the mechanism responsible for this is not understood. We transplanted DBA/2 (H-2(d)) kidneys into nephrectomized C57BL/6 (H-2(b)) mice, and the allografts were spontaneously accepted for >60 days without immunosuppression. In contrast, nonimmunosuppressed cardiac and skin allografts in the same strain combination are rejected within approximately 10 days. The accepted renal allografts have a prominent leukocytic infiltrate, suggesting an ongoing, local immune response. At 60 days post-transplant, the recipients of accepted renal allografts display DBA/2-reactive alloantibodies. They also display DBA/2-reactive delayed-type hypersensitivity responses that are actively counter-regulated by DBA/2-induced TGF-beta production, but not by IL-10 production. These data suggest that a donor-reactive, cell-mediated immune mechanism involving TGF-beta is associated with the spontaneous acceptance of renal allografts in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673485     DOI: 10.4049/jimmunol.167.9.4821

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Ultra-localization of Foxp3+ T cells within renal allografts shows infiltration of tubules mimicking rejection.

Authors:  Kathryn Brown; Victoria Moxham; Julieta Karegli; Richard Phillips; Steven H Sacks; Wilson Wong
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

3.  Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO.

Authors:  Charles H Cook; Alice A Bickerstaff; Jiao-Jing Wang; Tibor Nadasdy; Patricia Della Pelle; Robert B Colvin; Charles G Orosz
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 4.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

5.  Plasmacytoid Dendritic Cells and the Spontaneous Acceptance of Kidney Allografts.

Authors:  Mohamed B Ezzelarab; Angus W Thomson
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

6.  Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.

Authors:  Naoki Kohei; Toshiaki Tanaka; Kazunari Tanabe; Naoya Masumori; Nina Dvorina; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2016-04-28       Impact factor: 10.612

Review 7.  Organ-specific differences in achieving tolerance.

Authors:  Maria Lucia L Madariaga; Daniel Kreisel; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 8.  Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

9.  An experimental model of acute humoral rejection of renal allografts associated with concomitant cellular rejection.

Authors:  Alice Bickerstaff; Ronald Pelletier; Jiao-Jing Wang; Gyongyi Nadasdy; Nicholas DiPaola; Charles Orosz; Anjali Satoskar; Gregg Hadley; Tibor Nadasdy
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

10.  Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.

Authors:  Daisuke Ishii; Joshua M Rosenblum; Taiji Nozaki; Austin D Schenk; Kiyoshi Setoguchi; Charles A Su; Victoria Gorbacheva; William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.